Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Thromboelastography Applied in Diagnosing Normal and Complicated Pregnancies

By LabMedica International staff writers
Posted on 04 May 2022

During pregnancy, the coagulation system in women undergoes considerable changes to prevent bleeding. More...

If the coagulation system in pregnant women is not functioning optimally, incidents such as bleeding and miscarriage are prone to occur; if the coagulation system in pregnant women is hyperfunctional, the risk of venous thrombosis is high.

At present, many indicators such as activated partial prothrombin time and prothrombin time are used to detect blood coagulation function in the body. Thromboelastography (TEG), as a currently accessible laboratory test, can reflect the dynamic changes in the coagulation process and has high application value in evaluating platelet function.

Hematologists at the Affiliated Hospital of Hubei Polytechnic University (Huangshi, China) collected samples for 156 pregnant women with normal pregnancy (NP) and 58 women with threatened abortion (TA), 13 with missed abortion (MAb), 25 with embryo arrest (EA), four with fetal death (FD), six with a history of abnormal pregnancy (HAP), and seven with antiphospholipid antibody syndrome (AA).

TEG was performed using a BVCA-I thromboelastometer. The parameters R, K, α-angle, MA, LY-30, G, and coagulation index (CI) were analyzed. Partial correlation analysis was used to analyze correlation between groups of data. LSD-t test and Dunnett's T3 test were used to analyze continuous variables. Ordinal categorical variables were compared using ordinal logistic regression analysis and estimate odds ratio of risk factors. A receiver operating characteristic (ROC) curve was constructed to detect the ability of TEG to recognize various parameters, and areas under the curve were compared using Delong's test for diagnosing pregnancy-related diseases.

The scientists reported that there was no correlation between the data of NP and TA, and NP and FD groups; MAb had a negative effect on the MA parameter in TEG; EA had a negative effect on the MA and G parameters; HAP had a negative effect on the CI parameter and a positive effect on the R parameter; AA had a negative effect on the CI parameter. The team found that TEG parameters were different between some patient groups and control groups. For example, the CI value of the TA group was decreased, and the ratio of the angle value lower than the upper limit of the normal reference value was higher than that of the NP group, indicating that the coagulation function is low, and there could be a problem of inadequate fibrin levels or function.

The authors concluded that TEG has a good clinical significance in the diagnosis of TA, MAb, EA, AA, and HAP. The study was published on April 24, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
Affiliated Hospital of Hubei Polytechnic University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.